Tag Archive for Nasdaq First North

Zinzino Announces Peru as Next Step in Global Expansion

Zinzino is pleased to announce that it has launched its operations in Peru, as of February 10th, 2026.
Gothenburg, Sweden – Zinzino AB (publ) (ZZ-B.ST), a leading global direct selling company, reports that the company continues to strengthen its presence in Latin America with the launch of operations in Peru, which has generated monthly sales of approximately SEK 1.5 million through the company’s global web shop. The expansion builds on the company’s established success in existing Latin American markets, creating strong cross-border synergies for both partners and customers.
Peru offers attractive conditions for direct selling business, with a growing entrepreneurial culture and increasing demand for flexible income opportunities. At the same time, consumer interest in health, preventive care, and personalised nutrition solutions are rising, supporting long-term market potential for Zinzino’s science-based concept.

“Peru is a natural next step in our Latin American growth,”

says Dag Bergheim Pettersen, CEO of Zinzino.

“We see strong potential for our Peruvian Partners to build long-term success with our test-based concept.”

The launch will enable Zinzino’s Independent Partners to leverage the company’s existing regional infrastructure and experience as they develop the business locally. Zinzino’s digital platform and business model are well aligned with the Peruvian market, where digital commerce continues to expand

Read more...

LR Health & Beauty SE Reports FY2025 Results, Plans Bond Restructuring

LR Health & Beauty SE: Preliminary Results For Financial Year 2025, Target Equity Contribution, and Targeted Restructuring of the 2024/2028 Bonds. 
Ahlen, Germany – Based on the preliminary financial results for the financial year 2025, the Management Board of LR Health & Beauty SE (the “Company”) now expects an EBITDA* reported of around EUR 16 million for the financial year 2025 (previously expected to be between EUR 17.0 million and EUR 20.0 million). At the same time, the Management Board of the Company expects sales (revenue from goods sold) of around EUR 277 million for the full year 2025 (previously expected to be between EUR 276 million and EUR 281 million).
Also today, EY-Parthenon announced the completion of a draft IDW S 6 restructuring opinion in respect of the Company. Pursuant to the analysis set out in that draft restructuring opinion, the Company will for the financial year 2028 achieve an EBITDA* of EUR 27.3 million and sales of EUR 281.5 million in the sensitivity case, and an EBITDA* of EUR 31.4 million as well as sales of EUR 284.7 million in the management case.

Against this background, the Company decided today to enter into discussions with its shareholder and with the bondholders of the

Read more...